- Home
- / Alembic Pharmaceuticals
Alembic Pharmaceuticals
Stock Price
₹1.1 K
2024-10-29
Market Capitalization
₹214 B
2024-10-29
Revenue
₹73.4 B
FY, 2026
Alembic Pharmaceuticals Summary
Company Summary
- Overview
- Alembic Pharmaceuticals is a company that develops, manufactures, and markets pharmaceutical products, pharmaceutical substances, and intermediates. It covers dermatology, gastroenterology, ophthalmology, orthopedics, cardiology, gynecology, and animal health areas.
- Type
- Public
- Status
- Active
- Founded
- 2010
- HQ
- Vadodara, IN | view all locations
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Pranav Amin, Managing Director
Shaunak Amin, Managing Director
Raj Kumar Baheti, Director - Finance & CFO
Operating MetricsView all
SKUs
300
FY, 2022
Products
145
20.8%
FY, 2024
R&D Centers
2
FY, 2024
LocationsView all
6 locations detected
Vadodara, GJ HQ
India
Alembic Rd, Gorwa
Baska, GJ
India
Village Panelav, PO Tajpura
Mumbai, MH
India
2nd floor , Prime Corporate Park, Behind ITC Grand Maratha Sheraton, Sahar Road, Andheri (E)
Namthang, SK
India
Samardung Busty
Vadodara, GJ
India
Plot 401, 406-408, 410-412, 415, Halol Road, Jarod, Taluka Vaghodiya
Vadodara, GJ
India
Village Karkhadi, Padra Taluka
Alembic Pharmaceuticals Financials
Summary Financials
- Revenue (FY, 2026)
- ₹73.4B
- Gross profit (FY, 2026)
- ₹54.1B
- Net income (FY, 2026)
- ₹6.7B
- Cash (FY, 2026)
- ₹2.0B
- EBIT (FY, 2026)
- ₹7.9B
- Enterprise value
- $226.2B